Our manuscript “Accuracy and Prognosis of ENE on Radiologic Imaging in HPV+OPC: an HNCIG real-world study” is now published in IJROBP - The Red Journal . Read below! redjournal.org/article/S0360-…

Advanced Stage Head and Neck Cancer Diagnosis: HEADSpAcE Consortium Health Systems Benchmarking Survey - Creaney - Head & Neck - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/he…

What updates are there on Salivary Gland Cancers at #ASCO25? #HNCSM #headneck Here is the summary👇 ONCO BRUNO Oncology Brothers OncoAlert

Check this out 💫 Critical Issues in Head and Neck Oncology: Key Concepts from the Ninth THNO Meeting | SpringerLink link.springer.com/book/10.1007/9…

💥Keynote-689 Favourable DMFS HR 0.71, with half second tumors than SoC 🟠Keynote-412: Novel positive extended DMFS, but OS still negative ASCO #ASCO25 OncoAlert Oncology Brothers ONCO BRUNO #hncsm

Wonderful to see this out in the NEJM today. Structured exercise improves survival in colon cancer! Do come to see #ChrisBooth present in hall B1 at 4 30 PM today ASCO nejm.org/doi/full/10.10…

Enorme orgullo la colaboración de TTCC-GrupoTratamiento Tumores Cabeza y Cuello con GORTEC en el ensayo NIVOPOST OP presentado en la sesión plenaria de #ASCO25 que supondrá un cambio en la práctica clínica del cáncer de cabeza y cuello FETTCC Fundación E. Tto. Tumores Cabeza y Cuello

In NEJM Evidence: In patients with locoregionally advanced nasopharyngeal carcinoma, the 2-year failure-free survival of induction chemotherapy w/ gemcitabine & cisplatin followed by intensity-modulated radiation therapy was noninferior to concurrent cisplatin & radiation.

‼️ La infusión de inmunoterapia antes de las 15:00h demuestra mejor supervivencia libre de progresión que la administrada después de esa hora. Hoy en #ASCO25 oncólogos de todo el mundo hablan de ello a partir de los resultados de un Fase III en pacientes con cáncer de pulmón 👇🏻

‘Gift of life’: experts hail neck and head cancer breakthrough | Cancer | The Guardian theguardian.com/society/2025/m…

NIVOPOSTOP Trial Demonstrates DFS Benefit of Adjuvant Nivolumab in High-Risk HNSCC Following Chemoradiotherapy dailynews.ascopubs.org/do/nivopostop-…

Please beware that there are fake X accounts using my name for alternate therapies - I do not prescribe any such therapies and I also do not offer medical opinions on X.

Presentando la CyC-APP en representación de la FETTCC Fundación E. Tto. Tumores Cabeza y Cuello en la Reunión de Primavera SEORLCCC 💫! Gracias por la invitación y por ayudarnos a hacer difusion 😊 TTCC-GrupoTratamiento Tumores Cabeza y Cuello

Palbociclib, a Selective CDK4/6 Inhibitor, Administered Before and After Chemoradiotherapy for Human Papillomavirus–Negative, Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm, Phase II Trial | JCO Precision Oncology ascopubs.org/doi/abs/10.120…

NIVOPOSTOP Trial Demonstrates DFS Benefit of Adjuvant Nivolumab in High-Risk HNSCC Following Chemoradiotherapy dailynews.ascopubs.org/do/nivopostop-…

merck.com/news/fda-appro…

This is a HUGE moment for head and neck cancer - most importantly for patients with LA-HNSCC! Thanks to all the patients and families whom so generously participated in this trial. Grateful to the teams at Institut Català d'Oncologia and IDIBELL for their work in supporting this. 💪🏼🎊😊

This is a HUGE moment for head and neck cancer - most importantly for patients with LA-HNSCC! Thanks to all the patients and families whom so generously participated in this trial. Grateful to the teams at Institut Català d'Oncologia Hospital Universitari Bellvitge | HUB IDIBELL for their work in supporting it!

Segunda jornada de #PromesasVsSaurios Avances en #CáncerdeCabezayCuello, #Melanoma, #TumoresCerebrales y #Sarcoma Participan en la #Mesa3 la Dra. Ana Arance, Dra. Lara Iglesias, Dr. Marc Oliva Marc Oliva, Dra. Ángela Santiago y Dra. Ma Ángeles Sala

In patients with oral cavity squamous cell carcinoma, adjuvant chemotherapy is beneficial in patients with major extranodal extension (ENE), but may not be beneficial in patients with minor ENE. ja.ma/4kMfcOB